117 related articles for article (PubMed ID: 29976634)
1. Comparing Clonality Between Components of Combined Hepatocellular Carcinoma and Cholangiocarcinoma by Targeted Sequencing.
Jeon J; Maeng LS; Bae YJ; Lee EJ; Yoon YC; Yoon N
Cancer Genomics Proteomics; 2018; 15(4):291-298. PubMed ID: 29976634
[TBL] [Abstract][Full Text] [Related]
2. Multiregional analysis of combined hepatocellular-cholangiocarcinoma reveals histologic diversity and molecular clonality.
Na HY; Kim JH; Kim H; Cho JY; Han HS; Jang ES; Kim JW; Jeong SH; Heo J; Kim JW; Kim JW; Ahn S
Histopathology; 2024 Jan; 84(2):402-408. PubMed ID: 37903726
[TBL] [Abstract][Full Text] [Related]
3. Combined hepatocellular-cholangiocarcinoma: from genesis to molecular pathways and therapeutic strategies.
Gurzu S; Szodorai R; Jung I; Banias L
J Cancer Res Clin Oncol; 2024 May; 150(5):270. PubMed ID: 38780656
[TBL] [Abstract][Full Text] [Related]
4. Deep learning-based phenotyping reclassifies combined hepatocellular-cholangiocarcinoma.
Calderaro J; Ghaffari Laleh N; Zeng Q; Maille P; Favre L; Pujals A; Klein C; Bazille C; Heij LR; Uguen A; Luedde T; Di Tommaso L; Beaufrère A; Chatain A; Gastineau D; Nguyen CT; Nguyen-Canh H; Thi KN; Gnemmi V; Graham RP; Charlotte F; Wendum D; Vij M; Allende DS; Aucejo F; Diaz A; Rivière B; Herrero A; Evert K; Calvisi DF; Augustin J; Leow WQ; Leung HHW; Boleslawski E; Rela M; François A; Cha AW; Forner A; Reig M; Allaire M; Scatton O; Chatelain D; Boulagnon-Rombi C; Sturm N; Menahem B; Frouin E; Tougeron D; Tournigand C; Kempf E; Kim H; Ningarhari M; Michalak-Provost S; Gopal P; Brustia R; Vibert E; Schulze K; Rüther DF; Weidemann SA; Rhaiem R; Pawlotsky JM; Zhang X; Luciani A; Mulé S; Laurent A; Amaddeo G; Regnault H; De Martin E; Sempoux C; Navale P; Westerhoff M; Lo RC; Bednarsch J; Gouw A; Guettier C; Lequoy M; Harada K; Sripongpun P; Wetwittayaklang P; Loménie N; Tantipisit J; Kaewdech A; Shen J; Paradis V; Caruso S; Kather JN
Nat Commun; 2023 Dec; 14(1):8290. PubMed ID: 38092727
[TBL] [Abstract][Full Text] [Related]
5. Combined hepatocellular cholangiocarcinoma in hepatectomy specimens: A clinicopathologic analysis.
Patil N; Sahai P; Rastogi A; Sharma N; Shasthry SM; Mukund A; Laroia ST; Kumar G; Pamecha V; Sarin SK
Indian J Pathol Microbiol; 2023; 66(4):744-750. PubMed ID: 38084526
[TBL] [Abstract][Full Text] [Related]
6. Effect of liver transplantation in combined hepatocellular and cholangiocellular carcinoma: a case series.
Wu D; Shen ZY; Zhang YM; Wang J; Zheng H; Deng YL; Pan C
BMC Cancer; 2015 Apr; 15():232. PubMed ID: 25886479
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological features of combined hepatocellular-cholangiocarcinoma with sarcomatous change: Case report and literature review.
Gu Q; Yu X; Chen H; Chen G
Medicine (Baltimore); 2018 Jan; 97(3):e9640. PubMed ID: 29504997
[TBL] [Abstract][Full Text] [Related]
8. Combined Hepatocellular-Cholangiocarcinoma With Ductal Plate Malformation Pattern: A Case Report With Molecular Analysis.
Moon WS; Song JS; Yu HC; Kim KM; Ahn AR
Int J Surg Pathol; 2024 Feb; 32(1):160-164. PubMed ID: 37128663
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive analyses of the clinicopathological features and genomic mutations of combined hepatocellular-cholangiocarcinoma.
Ito T; Ishii T; Takeda H; Sumiyoshi S; Tomofuji K; Wakama S; Makino K; Horie H; Kumagai K; Takai A; Uebayashi EY; Ogiso S; Fukumitsu K; Haga H; Seno H; Hatano E
Hepatol Res; 2024 Jan; 54(1):103-115. PubMed ID: 37699724
[TBL] [Abstract][Full Text] [Related]
10. Molecular-based targeted therapies in patients with hepatocellular carcinoma and hepato-cholangiocarcinoma refractory to atezolizumab/bevacizumab.
Limousin W; Laurent-Puig P; Ziol M; Ganne-Carrié N; Nahon P; Ait-Omar A; Seror O; Sidali S; Campani C; Blanc P; Lermine A; Marisa L; Zucman-Rossi J; Nault JC
J Hepatol; 2023 Dec; 79(6):1450-1458. PubMed ID: 37647991
[TBL] [Abstract][Full Text] [Related]
11. Genetic Analyses of Primary Liver Cancer Cell Lines: Correspondence With Morphological Features of Original Tumors.
Akiba J; Ogasawara S; Yano H
Cancer Genomics Proteomics; 2024; 21(3):260-271. PubMed ID: 38670592
[TBL] [Abstract][Full Text] [Related]
12. Possibility of Cell Block Specimens from Overnight-Stored Bile for Next-Generation Sequencing of Cholangiocarcinoma.
Okuno M; Kanayama T; Iwata K; Tanaka T; Tomita H; Iwasa Y; Shirakami Y; Watanabe N; Mukai T; Tomita E; Shimizu M
Cells; 2024 May; 13(11):. PubMed ID: 38891057
[TBL] [Abstract][Full Text] [Related]
13. Hepatocellular Carcinomas with Concomitant Mutations of TERT, TP53, and CTNNB1: Is There a Role for Artificial Intelligence?
Chillotti S; Maloberti T; Degiovanni A; Malvi D; D'Errico A; de Biase D; Vasuri F
Crit Rev Oncog; 2023; 28(3):31-35. PubMed ID: 37968991
[TBL] [Abstract][Full Text] [Related]
14. How Molecular Discoveries Have Changed Liver Tumor Pathology: A Brief Review.
Taheri N; Graham RP
Arch Pathol Lab Med; 2024 May; 148(5):e96-e102. PubMed ID: 37639429
[TBL] [Abstract][Full Text] [Related]
15. Molecular Profiling of a Hepatocellular Neoplasm Not Otherwise Specified (HCN-NOS) Demonstrates Distinct Molecular Features in Hepatoblastoma and HCC-Like Components.
Chen Wongworawat Y; Sarabia SF; Urbicain M; Francalanci P; Sumazin P; Alaggio R; López-Terrada DH
Pediatr Dev Pathol; 2024; 27(2):169-175. PubMed ID: 37903123
[TBL] [Abstract][Full Text] [Related]
16. Practical considerations for pathological diagnosis and molecular profiling of cholangiocarcinoma: an expert review for best practices.
Evans M; Kendall T
Expert Rev Mol Diagn; 2024 May; 24(5):393-408. PubMed ID: 38752560
[TBL] [Abstract][Full Text] [Related]
17. Current advances and future directions in combined hepatocellular and cholangiocarcinoma.
Zhang YZ; Liu YC; Su T; Shi JN; Huang Y; Liang B
Gastroenterol Rep (Oxf); 2024; 12():goae031. PubMed ID: 38628397
[TBL] [Abstract][Full Text] [Related]
18. Clonal evolution in liver cancer at single-cell and single-variant resolution.
Su X; Zhao L; Shi Y; Zhang R; Long Q; Bai S; Luo Q; Lin Y; Zou X; Ghazanfar S; Tao K; Yang G; Wang L; He KY; Cui X; He J; Wu JX; Han B; Yan B; Deng B; Wang N; Li X; Yang P; Hou S; Sun J; Yang JYH; Chen J; Han ZG
J Hematol Oncol; 2021 Feb; 14(1):22. PubMed ID: 33531041
[TBL] [Abstract][Full Text] [Related]
19. Characterization of tumor evolution by functional clonality and phylogenetics in hepatocellular carcinoma.
Kacar Z; Slud E; Levy D; Candia J; Budhu A; Forgues M; Wu X; Raziuddin A; Tran B; Shetty J; Pomyen Y; Chaisaingmongkol J; Rabibhadana S; Pupacdi B; Bhudhisawasdi V; Lertprasertsuke N; Auewarakul C; Sangrajrang S; Mahidol C; Ruchirawat M; Wang XW
Commun Biol; 2024 Mar; 7(1):383. PubMed ID: 38553628
[TBL] [Abstract][Full Text] [Related]
20. Genomic and Transcriptomic Profiling of Combined Hepatocellular and Intrahepatic Cholangiocarcinoma Reveals Distinct Molecular Subtypes.
Xue R; Chen L; Zhang C; Fujita M; Li R; Yan SM; Ong CK; Liao X; Gao Q; Sasagawa S; Li Y; Wang J; Guo H; Huang QT; Zhong Q; Tan J; Qi L; Gong W; Hong Z; Li M; Zhao J; Peng T; Lu Y; Lim KHT; Boot A; Ono A; Chayama K; Zhang Z; Rozen SG; Teh BT; Wang XW; Nakagawa H; Zeng MS; Bai F; Zhang N
Cancer Cell; 2019 Jun; 35(6):932-947.e8. PubMed ID: 31130341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
